Compare RVMD & DOCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RVMD | DOCS |
|---|---|---|
| Founded | 2014 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2B | 12.3B |
| IPO Year | 2020 | 2021 |
| Metric | RVMD | DOCS |
|---|---|---|
| Price | $121.05 | $40.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 20 |
| Target Price | ★ $81.19 | $67.70 |
| AVG Volume (30 Days) | ★ 4.8M | 2.7M |
| Earning Date | 02-25-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 42.88 |
| EPS | N/A | ★ 1.25 |
| Revenue | N/A | ★ $621,329,000.00 |
| Revenue This Year | N/A | $15.39 |
| Revenue Next Year | $714.50 | $11.07 |
| P/E Ratio | ★ N/A | $33.12 |
| Revenue Growth | N/A | ★ 20.21 |
| 52 Week Low | $29.17 | $41.34 |
| 52 Week High | $121.62 | $85.21 |
| Indicator | RVMD | DOCS |
|---|---|---|
| Relative Strength Index (RSI) | 89.60 | 31.29 |
| Support Level | $76.28 | $43.46 |
| Resistance Level | $121.62 | $44.18 |
| Average True Range (ATR) | 5.89 | 1.66 |
| MACD | 4.05 | 0.02 |
| Stochastic Oscillator | 97.30 | 5.44 |
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.